The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | L | Antineoplastic and immunomodulating agents | |
| 2 | L03 | Immunostimulants | |
| 3 | L03A | Immunostimulants | |
| 4 | L03AX | Other immunostimulants | |
| 5 | L03AX21 |
| Active Ingredient | Description | |
|---|---|---|
| Elapegademase |
Elapegademase is a recombinant adenosine deaminase (rADA). It provides an exogenous source of ADA enzyme that is associated with a decrease in toxic adenosine and deoxyadenosine nucleotides levels as well as an increase in lymphocyte number. Severe combined immune deficiency (SCID) associated with a deficiency of ADA enzyme is a rare, inherited, and often fatal disease. |
